Alcidion Group Limited (AU:ALC)
ASX:ALC
ALC Stock Chart & Stats
AU$0.10
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.10
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.06 - AU$0.15
Previous CloseN/A
Volume609.88K
Average Volume (3M)796.98K
Market Cap
AU$134.30M
Enterprise ValueAU$121.42M
Total Cash (Recent Filing)AU$14.20M
Total Debt (Recent Filing)AU$1.32M
Price to Earnings (P/E)26.5
Beta1.14
Next Earnings
Sep 02, 2026EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding1,342,952,600
10 Day Avg. Volume536,053
30 Day Avg. Volume796,979
Financial Highlights & Ratios
PEG Ratio-0.70
Price to Book (P/B)1.57
Price to Sales (P/S)3.38
P/FCF Ratio24.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.14Price Target Upside40.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)<0.01
Revenue Forecast (FY)AU$51.40M
Bulls Say, Bears Say
Bulls Say
Recurring SaaS And Services Revenue ModelAlcidion's mix of subscription licensing, implementation, support and expansion revenue creates durable, sticky cash flows and multiple monetization levers. Long-term contracts with hospitals support predictable recurring revenue, upsell potential and high customer retention once integrated.
Very High Gross Margin And Strong Free Cash Flow GrowthAn 88% gross margin provides a wide buffer to absorb operating investment while protecting profitability as scale increases. The dramatic free cash flow improvement shows the business can convert earnings into cash, supporting reinvestment, debt-light growth and resilience through procurement cycles.
Very Low Leverage And Solid Balance Sheet FlexibilityExtremely low leverage gives Alcidion financial flexibility to fund deployments, R&D or M&A without needing external financing. This reduces solvency risk versus peers, helps weather long healthcare procurement cycles and supports strategic investments that can drive durable growth.
Bears Say
Negative EBIT Margin (operating Loss)Despite high gross margins, negative EBIT signals operating expenses outpacing core profitability. Persisting operating losses require continued scale or sustained cost control to reach durable operating profitability; otherwise margin recovery may be slow and dependent on execution.
Thin Net Profitability And Low Shareholder ReturnsLow net margin and modest ROE indicate limited ability to convert revenue into shareholder returns today. This constrains internal funding capacity for growth investments and may necessitate either slower organic expansion or external funding, diluting long-term capital efficiency.
Concentration In Healthcare Systems And Limited ScaleReliance on public health systems across a few markets exposes Alcidion to long procurement cycles, political budgeting and slow rollouts. With ~145 employees, execution and large-scale simultaneous deployments may be constrained, slowing market share expansion and margin leverage from scale.
Alcidion Group Limited News
ALC FAQ
What was Alcidion Group Limited’s price range in the past 12 months?
Alcidion Group Limited lowest share price was AU$0.06 and its highest was AU$0.14 in the past 12 months.
What is Alcidion Group Limited’s market cap?
Alcidion Group Limited’s market cap is AU$134.30M.
When is Alcidion Group Limited’s upcoming earnings report date?
Alcidion Group Limited’s upcoming earnings report date is Sep 02, 2026 which is in 150 days.
How were Alcidion Group Limited’s earnings last quarter?
Alcidion Group Limited released its earnings results on Feb 25, 2026. The company reported AU$0.001 earnings per share for the quarter, beating the consensus estimate of AU$0 by AU$0.001.
Is Alcidion Group Limited overvalued?
According to Wall Street analysts Alcidion Group Limited’s price is currently Undervalued.
Does Alcidion Group Limited pay dividends?
Alcidion Group Limited does not currently pay dividends.
What is Alcidion Group Limited’s EPS estimate?
Alcidion Group Limited’s EPS estimate is <0.01.
How many shares outstanding does Alcidion Group Limited have?
Alcidion Group Limited has 1,342,952,600 shares outstanding.
What happened to Alcidion Group Limited’s price movement after its last earnings report?
Alcidion Group Limited reported an EPS of AU$0.001 in its last earnings report, beating expectations of AU$0. Following the earnings report the stock price went down -4.545%.
Which hedge fund is a major shareholder of Alcidion Group Limited?
Currently, no hedge funds are holding shares in AU:ALC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Alcidion Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$0.14 (40.00% Upside)
AU$0.14 (40.00% Upside)
Blogger Sentiment
Bullish
AU:ALC Sentiment 95%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.66%
12-Months-Change
Fundamentals
Return on Equity
4.37%
Trailing 12-Months
Asset Growth
3.82%
Trailing 12-Months
Company Description
Alcidion Group Limited
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a consolidated fast healthcare interoperability resource (FHIR) based platform to deliver smart healthcare; Smartpage, a smartphone and web-based system for hospital communication and task management to address the requirements of clinical and non-clinical users; Patientrack, a real-time patient monitoring and risk screening solution; Silverlink, a patient administration system; and ExtraMed, a clinical and patient flow management software. It also provides product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.
ALC Stock 12 Month Forecast
Average Price Target
AU$0.14
▲(40.00% Upside)
Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1
―
Mach7 Technologies
―
Beamtree Holdings Ltd
―
Singular Health Group Ltd
―
PainChek Ltd
―
Options Prices
Currently, No data available
---